Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

It’s not yet entirely clear why GLP-1 drugs help with addiction, but it may have to do with the overlap between the appetite circuits in the brain with the reward pathways involved in addiction ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

When I tell people I direct clinical research studies, I often encounter surprise. “Aren’t you a physician?” they ask. It ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.